We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

38 hedge funds and large institutions have $1.13B invested in Vaxcyte in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

74.29% more ownership

Funds ownership: 0% → 74.29% (+74%)

Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$177M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$166M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$152M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$151M
5
A
Abingworth
United Kingdom
+$134M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$174M +$177M +5,489,181 New
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$163M +$166M +5,156,553 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$149M +$151M +4,706,759 New
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$140M +$152M +4,725,792 New
A
5
Abingworth
United Kingdom
$132M +$134M +4,168,718 New
FM
6
Frazier Management
Washington
$73M +$74.3M +2,309,554 New
MVM
7
Medicxi Ventures Management
Jersey
$59.7M +$60.7M +1,887,478 New
Wellington Management Group
8
Wellington Management Group
Massachusetts
$37.9M +$38.6M +1,200,000 New
NHAS
9
Novo Holdings A/S
Denmark
$27.9M +$28.4M +881,898 New
Millennium Management
10
Millennium Management
New York
$27.4M +$27.9M +868,318 New
O
11
OrbiMed
New York
$26.9M +$27.3M +850,000 New
PA
12
Perceptive Advisors
New York
$26.9M +$27.3M +850,000 New
FCMI
13
Foresite Capital Management IV
California
$19.6M +$20M +620,821 New
Citadel Advisors
14
Citadel Advisors
Florida
$17.4M +$17.7M +549,751 New
LGM
15
Logos Global Management
California
$14.4M +$14.6M +455,000 New
Franklin Resources
16
Franklin Resources
California
$12.7M +$12.9M +400,070 New
VOYA Investment Management
17
VOYA Investment Management
Georgia
$6.52M +$6.64M +206,322 New
IC
18
Ikarian Capital
Texas
$4.42M +$4.5M +139,813 New
Goldman Sachs
19
Goldman Sachs
New York
$2.76M +$2.81M +87,424 New
MIM
20
Monashee Investment Management
Massachusetts
$2.53M +$2.57M +80,000 New
BlackRock
21
BlackRock
New York
$2.52M +$2.57M +79,812 New
MWNA
22
Marshall Wace North America
New York
$1.23M +$1.25M +38,856 New
Vanguard Group
23
Vanguard Group
Pennsylvania
$948K +$965K +30,000 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$806K +$821K +25,526 New
WP
25
Woodline Partners
California
$728K +$740K +23,026 New
1
2

PCVX Hedge Fund Activity: Q2 2020 in Review

38 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q2 2020, worth a combined $1.13B.

Buyers outnumbered sellers: 38 funds opened new PCVX positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $177M.

  • 38 institutional investors held Vaxcyte (PCVX) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1.13B of Vaxcyte stock for Q2 2020.
  • 38 funds opened new Vaxcyte positions in Q2 2020 and 0 closed out, a net change of +38 holders.
  • The largest Vaxcyte buyer in Q2 2020 was RA Capital Management, an estimated $177M added.

Based on aggregated 13F filings for Q2 2020.